權重股拖累科指續跌1.3%創逾一年低 京東健康(06618.HK)續跌逾4%創上市新低
恆生科指連跌第三天兼屢創逾一年低,現報3,359,續跌1.3%。此外,恆指承過去兩連跌勢,今早低開186點或1.1%,報16,030(守穩上月11日盤中所創低位15,972),曾回升至16,197無以為繼,現報16,043,續跌173點或近1.1%,總成交額298億元。
30隻科指成份股逾普遍受壓。權重股騰訊(00700.HK)扭三連升,股價重失10天線,最低見283元,現報283.4元,回吐2.1%。美團(03690.HK)也重失10天線(75元),高低見76.2元/73.85元,現報73.95元,反覆回吐2.2%。阿里巴巴(09988.HK)及京東(09618.HK)連跌第三天,最低見68.85元及94.55元,現報69元及94.75元,續跌1.4%及2%。
舜宇(02382.HK)低見57.7元創逾三個月低,現報57.8元,續跌2.7%。聯想(00992.HK)連跌第三天兼失守10天及20天線,現報10.14,續跌3.6%。
三大醫療平台股跌1.6%-4.5%,京東健康(06618.HK)沽壓最大,股價一舉跌破52周低位(31.5元)及2022年3月所創上市低位(31.4元),最低見30.4元,現報30.7元,續跌4.5%,為表現最差科指成份股及及藍籌。
然而,百度(09888.HK)就「文心」大模型報道作出澄清指,集團與學術論文作者或其所屬機構無任何合作,股價曾反彈4.3%至104.8元遇壓,現報102.7元,回升2.2%。
攜程(09961.HK)及比亞迪電子(00285.HK)回升1.8%及2%,報295.4元及32.85元,前者股價重越10天線(292.1元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.